Valiant Laboratories Limited

Valiant Laboratories Limited (VALIANTLAB) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

valiantlabs.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹96.13
Market cap
521 Cr
Stock P/E
59.6
P/B
1.68

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales60 Cr41 Cr31 Cr19 Cr21 Cr35 Cr58 Cr47 Cr46 Cr52 Cr92 Cr115 Cr
Operating expenses (approx.)61 Cr47 Cr35 Cr21 Cr28 Cr35 Cr54 Cr44 Cr46 Cr53 Cr87 Cr86 Cr
EBITDA-1 Cr-6 Cr-5 Cr-2 Cr-7 Cr0.62 Cr4 Cr2 Cr0.08 Cr-0.89 Cr5 Cr29 Cr
OPM %-2.3%-15.6%-14.8%-12.6%-31.4%1.8%6.6%5.1%0.2%-1.7%5.2%25.4%
Other income3 Cr2 Cr3 Cr3 Cr3 Cr2 Cr-2 Cr0.66 Cr0.87 Cr0.63 Cr0.17 Cr0.86 Cr
Interest0.02 Cr0.02 Cr0.02 Cr0.05 Cr0.0061 Cr0.06 Cr0.05 Cr0.07 Cr0.14 Cr0.68 Cr1 Cr1 Cr
Depreciation0.49 Cr0.49 Cr0.52 Cr0.53 Cr0.52 Cr0.52 Cr0.52 Cr0.53 Cr0.53 Cr2 Cr3 Cr3 Cr
Profit before tax1 Cr-5 Cr-3 Cr-0.16 Cr-4 Cr2 Cr0.94 Cr2 Cr0.28 Cr-3 Cr1 Cr26 Cr
Tax %25.4%30.6%51.7%-214.4%-21.3%-44.9%25.1%25.6%27.6%-136.0%-68.0%19.4%
Net profit0.79 Cr-4 Cr-1 Cr-0.51 Cr-5 Cr2 Cr0.70 Cr2 Cr0.20 Cr-7 Cr2 Cr21 Cr
EPS (₹)₹0.24₹-0.81₹-0.33₹-0.12₹-1.09₹0.54₹0.16₹0.42₹0.04₹-1.30₹0.32₹3.89

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales182 Cr133 Cr237 CrSign in for TTM
Operating expenses (approx.)190 Cr138 Cr231 CrSign in for TTM
EBITDA-8 Cr-5 Cr6 CrSign in for TTM
OPM %-4.6%-3.5%2.7%Sign in for TTM
Other income10 Cr5 Cr2 CrSign in for TTM
Interest0.08 Cr0.18 Cr2 CrSign in for TTM
Depreciation2 Cr2 Cr6 CrSign in for TTM
Profit before tax-0.77 Cr-2 Cr0.77 CrSign in for TTM
Tax %141.5%-45.5%525.4%Sign in for TTM
Net profit0.32 Cr-2 Cr-3 CrSign in for TTM
EPS (₹)₹0.13₹-0.51₹-0.51Sign in for TTM
Dividend payout %0.0%——Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital43 Cr43 Cr54 Cr
Reserves193 Cr191 Cr257 Cr
Borrowings76 Cr121 Cr45 Cr
Other liabilities30 Cr45 Cr108 Cr
Total liabilities343 Cr401 Cr464 Cr
Fixed assets (net)50 Cr48 Cr227 Cr
CWIP43 Cr156 Cr6 Cr
Investments38 Cr0 Cr26 Cr
Loans & advances0.03 Cr0.06 Cr0.04 Cr
Inventories10 Cr4 Cr45 Cr
Trade receivables46 Cr72 Cr94 Cr
Cash & bank12 Cr5 Cr4 Cr
Other assets145 Cr116 Cr62 Cr
Total assets343 Cr401 Cr464 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity2 Cr1 Cr-10 Cr
Cash from investing-144 Cr-53 Cr7 Cr
Cash from financing152 Cr45 Cr2 Cr
Net cash flow10 Cr-7 Cr-1 Cr
Free cash flow (OCF − Capex)-44 Cr-113 Cr-45 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %-0.2%-0.4%0.8%
ROE %0.1%-0.9%-1.1%
Debtor days92197143
Inventory days221387
Days payable56132179
Cash conversion cycle577851
Debt / equity0.320.520.14
Current ratio7.763.231.91
Net debt / EBITDA——6.48

Compare with peers

Loading peers…